Flucloxacillin
Jump to navigation
Jump to search
![]() | |
---|---|
![]() | |
Systematic (IUPAC) name | |
(2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | |
Identifiers | |
CAS number | 5250-39-5 |
ATC code | J01CF05 QJ51CF05 |
PubChem | CID 21319 |
DrugBank | APRD00609 |
ChemSpider | 20037 ![]() |
UNII | 43B2M34G2V ![]() |
KEGG | D04196 ![]() |
ChEMBL | CHEMBL222645 ![]() |
Chemical data | |
Formula | |
Mol. mass | 453.87 g/mol |
SMILES | eMolecules & PubChem |
| |
Pharmacokinetic data | |
Bioavailability | 50–70% |
Metabolism | Hepatic |
Half-life | 0.75–1 hour |
Excretion | Renal |
Therapeutic considerations | |
Pregnancy cat. | B1(AU) |
Legal status | Prescription Only (S4) (AU) POM (UK) |
Routes | Oral, IM, IV, intrapleural, intraarticular |
![]() |
Flucloxacillin ose floxacillin është një antibiotik kundër baktereve Gram-pozitive.